Existen situaciones especficas donde puede ser necesario interrumpir temporalmente o permanentemente el tratamiento, como embarazo planificado o en curso, intolerancia persistente a efectos secundarios, desarrollo de contraindicaciones, o problemas de acceso o cobertura del seguro mdico
That GLP-1/GCGR co-agonism can improve glucose, lipid and energy metabolism has subsequently also been demonstrated in human studies [116, 117], and a series of co-agonists have advanced to clinical development for the treatment of type 2 diabetes, non-alcoholic steatohepatitis and obesity (as reviewed previously [117])
I have been doing this consistently for [time period]
Can Wegovy (semaglutide) be used in combination with berberine for type 2 diabetes or weight loss?
Kreuzer PM, Landgrebe M, Vielsmeier V, Kleinjung T, De Ridder D, Langguth B
Duration of effect questions will eventually be answered in long-term RCTs but there may also be short-term opportunities for more granular retrospective studies examining this question